Document is current
Any future updates will be listed below
-
Authors
Graetz, Ilana https://orcid.org/0000-0003-3664-5815
McKillop, Caitlin N.
Stepanski, Edward
Vidal, Gregory A.
Anderson, Janeane N.
Schwartzberg, Lee S.
-
Funding
Funding for this research was provided by:
the University of Tennessee Health Science Center Clinical and Translational Science Institute
National Cancer Institute (R01CA218155)
- License Information
-
More Information
Article History
Received: 10 July 2017
Accepted: 12 February 2018
First Online: 28 February 2018
Compliance with ethical standards
: Informed consent was obtained from all individual participants included in the study. The University of Tennessee Health Science Center Institutional Review Board approved the study protocol. This trial is registered at , number NCT02957526.
: Drs. Graetz, Anderson, and McKillop declare that they have no conflict of interest. Drs. Stepanski and Schwartzberg own stock in Vector Oncology. Dr. Vidal received a speaker honorarium from Pfizer Inc. and AstraZeneca.
